ATOSSA THERAPEUTICS INC. - COMMON STOCK

1.5750

20-May-24 14:37:41

15 minutes delayed

Stocks

+0.0050

+0.32%

Today's range

1.5350 - 1.6182

ISIN

N/A

Source

NASDAQ

Atossa Therapeutics Granted Additional Patent Protection for Endoxifen

21 Jun 2023 09:13:54 By Nasdaq GlobeNewswire
Atossa to Participate in Fireside Chat at Healthcare Virtual Conference Presented by Maxim Group LLC

14 Jun 2023 08:15:00 By Nasdaq GlobeNewswire
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer

12 Jun 2023 08:15:00 By Nasdaq GlobeNewswire
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer

01 Jun 2023 08:10:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.